Tuberculosis: all 1,435 studies

Page 4 of 15. Open to participants first (208), then studies with results posted, then the rest; newest registration first within each.

• Evaluation of the QuantiFERON-TB Test.CompletedNCT02256839Results posted
• Assessing PA-824 for Tuberculosis (the APT Trial)CompletedNCT02256696Phase 2Results posted
• Evaluation of the QuantiFERON-TB Test.CompletedNCT02253537Results posted
• A Phase 2 to Evaluate the Efficacy, Safety and Tolerability of Combinations of Bedaquiline, Moxifloxacin, PA-824 and Pyrazinamide in Adult Subjects With Drug-Sensitive or Multi Drug-Resistant Pulmonary Tuberculosis.CompletedNCT02193776Phase 2Results posted
• Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infectionCompletedNCT02178592Phase 3Results posted
• Optimization of the TB Treatment Regimen CascadeCompletedNCT02153528Phase 3Results posted
• Evaluation of the QuantiFERON-TB Test.CompletedNCT02142894Results posted
• Improving Retreatment Success (IMPRESS)CompletedNCT02114684Phase 1/2Results posted
• Development of Human Nasal Challenge Models With Microbial Constituents and Grass PollenCompletedNCT02090374Not applicableResults posted
• Innovative Approach in Tuberculosis Care in ArmeniaCompletedNCT02082340Not applicableResults posted
• Evaluation of Safety, Immunogenicity, and Prevention of TB With AERAS-404 and BCG Revaccination in Healthy AdolescentsCompletedNCT02075203Phase 2Results posted
• Dose-Escalation Study to Evaluate the Safety and Immunogenicity of MTBVAC Vaccine in Comparison With BCG Vaccine.CompletedNCT02013245Phase 1Results posted
• Phase I Clinical Human Tolerability Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10CompletedNCT01999231Phase 1Results posted
• Safety and Immunogenicity Study of AERAS-456 Vaccine for TuberculosisCompletedNCT01967134Phase 1Results posted
• Wirelessly Observed Therapy in Comparison to Directly Observed Therapy for the Treatment of TuberculosisCompletedNCT01960257Phase 4Results posted
• High-Dose Isoniazid Among Adult Patients With Different Genetic Variants of INH-Resistant Tuberculosis (TB)CompletedNCT01936831Phase 2Results posted
• Efficacy and Safety of Levofloxacin for the Treatment of MDR-TBCompletedNCT01918397Phase 2Results posted
• A Phase I/IIa AERAS-456 in HIV-Negative Adults With & Without Latent Tuberculosis Infection (C-035-456)CompletedNCT01865487Phase 1/2Results posted
• Sustainable East Africa Research in Community HealthCompletedNCT01864603Not applicableResults posted
• A 6-Month Safety, Efficacy, and Pharmacokinetic (PK) Trial of Delamanid in Pediatric Participants With Multidrug Resistant Tuberculosis (MDR-TB)CompletedNCT01859923Phase 2Results posted
• Evaluation of SQ109, High-dose Rifampicin, and Moxifloxacin in Adults With Smear-positive Pulmonary TB in a MAMS DesignCompletedNCT01785186Phase 2Results posted
• Indacaterol EfectIveness In COPD Patients With Tuberculosis HistoryCompletedNCT01778062Phase 3Results posted
• Study to Evaluate the Efficacy of GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine in AdultsCompletedNCT01755598Phase 2Results posted
• Safety, Tolerance and Pharmacokinetics of Raltegravir-Containing Antiretroviral Therapy in Infants, Children Infected With HIV and TBCompletedNCT01751568Phase 1/2Results posted
• Comparative Study of Bacille Calmette Guerin (BCG) Delivery Via Disposable Syringe Jet Injector and Needle & SyringeCompletedNCT01742364Not applicableResults posted
• Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis With Clofazimine (C)-TMC207 (J)-PA-824 (Pa)-Pyrazinamide (Z)CompletedNCT01691534Phase 2Results posted
• Study in Healthy Adults to Evaluate Gene Activation After Vaccination With GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine GSK 692342CompletedNCT01669096Phase 2Results posted
• Effects of a Protein Calorie Supplement in HIV-infected Women With TuberculosisCompletedNCT01635153Not applicableResults posted
• Directly Observed Therapy Short Course-Plus Versus DOTS for Retreatment of Relapsed Pulmonary Tuberculosis in GuangzhouCompletedNCT01618422Not applicableResults posted
• Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in Persons With HIVTerminatedNCT01601626Phase 2Results posted
• Essentiality of INH in TB TherapyCompletedNCT01589497Phase 2Results posted
• Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOTCompletedNCT01582711Phase 3Results posted
• Cell Phone Messaging to Improve Communication of Critical Laboratory Results to Patients in Rural UgandaCompletedNCT01579214Not applicableResults posted
• Drug Interaction Study Between Linezolid and Clarithromycin in Tuberculosis PatientsCompletedNCT01521364Phase 4Results posted
• Evaluation of 8 Weeks of Treatment With the Combination of Moxifloxacin, PA-824 and Pyrazinamide in Patients With Drug Sensitive and Multi Drug-Resistant Pulmonary Tuberculosis (TB) (NC-002)CompletedNCT01498419Phase 2Results posted
• Evaluating the Safety of Immediate Versus Deferred Isoniazid Preventive Therapy Among HIV-Infected Pregnant WomenCompletedNCT01494038Phase 4Results posted
• Safety and Efficacy Trial of Delamanid for 6 Months in Participants With Multidrug-resistant TuberculosisCompletedNCT01424670Phase 3Results posted
• Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Adults With TB DiseaseTerminatedNCT01424501Phase 2Results posted
• Trial of High-Dose Rifampin in Patients With TBCompletedNCT01408914Phase 2Results posted
• Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)CompletedNCT01404312Phase 3Results posted
• REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) TreatmentCompletedNCT01380080Phase 4Results posted
• Xpert MTB/Rif, a New Tool for the Diagnosis of Pulmonary Tuberculosis in Two Municipalities in BrazilCompletedNCT01363765Phase 4Results posted
• Universal Screening for Tuberculosis and Anemia With the CHICA SystemCompletedNCT01322841Not applicableResults posted
• Bioequivalence Study Comparing Rifampicin In A Fixed-Dose Combination (Rifampicin+Isoniazid, Myrin© 2) And The Reference Drug (Rifampicin, Rimactane®)CompletedNCT01311505Phase 1Results posted
• Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Human Immunodeficiency Virus (HIV)-Positive AdultsCompletedNCT01262976Phase 2Results posted
• Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis With(J-M-Pa-Z) (NC-001)CompletedNCT01215851Phase 2Results posted
• Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis (TMC207-CL001)CompletedNCT01215110Phase 2Results posted
• Study of AERAS-402 in Healthy InfantsCompletedNCT01198366Phase 1/2Results posted
• Effect of Weight and/or Obesity on Sulfamethoxazole and Trimethoprim ConcentrationsCompletedNCT01167452Phase 4Results posted
• Effect of Weight and/or Obesity on Dapsone Drug ConcentrationsCompletedNCT01165840Phase 4Results posted
• Pharmacokinetics, Safety and Tolerability of Escalating Rifapentine Doses in Healthy VolunteersCompletedNCT01162486Phase 1Results posted
• Efficacy Against TB Disease, Safety, and Immunogenicity of MVA85A/AERAS-485 in HIV-Infected Adults (C-030-485)CompletedNCT01151189Phase 2Results posted
• The Impact of Vitamin D on Tuberculosis Among KoreansCompletedNCT01137370Results posted
• Safety and Pharmacokinetics (PK) in Multidrug-Resistant (MDR) Refractive TuberculosisTerminatedNCT01131351Phase 2Results posted
• Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Healthy InfantsCompletedNCT01098474Phase 2Results posted
• Effect of Weight and/or Obesity on Ethambutol Drug ConcentrationsCompletedNCT01048697Phase 4Results posted
• Safety and Immunogenicity of AERAS-402 in HIV-infected, Bacillus Calmette-Guerin (BCG)-Vaccinated AdultsCompletedNCT01017536Phase 2Results posted
• Diagnosis of Tuberculosis Infection in Health Care Workers Using Ex-vivo Interferon-gamma AssayCompletedNCT01007396Not applicableResults posted
• A Study of MVA85A in Healthy InfantsCompletedNCT00953927Phase 2Results posted
• Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in Healthy HIV Negative AdolescentsCompletedNCT00950612Phase 2Results posted
• Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis (CL-010)CompletedNCT00944021Phase 2Results posted
• To Evaluate the Safety, Tolerability, and Efficacy of TMC207 as Part of an Individualized Multi-drug Resistant Tuberculosis (MDR-TB) Treatment Regimen in Participants With Sputum Smear-positive Pulmonary MDR-TB.CompletedNCT00910871Phase 2Results posted
• Controlled Comparison of Two Moxifloxacin Containing Treatment Shortening Regimens in Pulmonary TuberculosisCompletedNCT00864383Phase 3Results posted
• Tuberculosis and Human Immunodeficiency Virus (HIV) Immune Reconstitution Syndrome Trial (THIRST)CompletedNCT00851630Phase 4Results posted
• Study of Daily Rifapentine for Pulmonary TuberculosisCompletedNCT00814671Phase 2Results posted
• Safety And Efficacy Of Rifabutin In HIV PatientsCompletedNCT00810446Results posted
• Safety And Efficacy Of Rifabutin In Patients For Non-HIV PatientsCompletedNCT00810407Results posted
• Screening for Latent Tuberculosis Infection (LTBI) in US Army RecruitsCompletedNCT00804713Not applicableResults posted
• Rifapentine Plus Moxifloxacin for Treatment of Pulmonary TuberculosisTerminatedNCT00728507Phase 2Results posted
• Linezolid to Treat Extensively-Drug Resistant TuberculosisCompletedNCT00727844Phase 2Results posted
• Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine in HIV-positive Adults.CompletedNCT00707967Phase 2Results posted
• A Trial to Evaluate OPC 67683 in Participants With Pulmonary Sputum Culture-positive, Multidrug-resistant Tuberculosis (TB)CompletedNCT00685360Phase 2Results posted
• Safety and Immunogenicity Study of GSK Biologicals Tuberculosis Vaccines (692342) to Healthy AdultsCompletedNCT00621322Phase 2Results posted
• Immunobiology of Diabetes and TuberculosisTerminatedNCT00568854Not applicableResults posted
• PA-824-CL-007: Phase IIa Evaluation of Early Bactericidal Activity in Pulmonary TuberculosisCompletedNCT00567840Phase 2Results posted
• Clinical Trial to Study 4 Different Doses of the Vaccine RUTI in Healthy VolunteersCompletedNCT00546273Phase 1Results posted
• Efficacy and Safety of Activase (Ateplase) vs Placebo in Complicated Pleural Effusions (CPE)/EmpyemasCompletedNCT00468104Not applicableResults posted
• TMC207-TiDP13-C208: Anti-bacterial Activity, Safety, and Tolerability of TMC207 in Participants With Multi-drug Resistant Mycobacterium Tuberculosis (MDR-TB).CompletedNCT00449644Phase 2Results posted
• Metronidazole for Pulmonary Tuberculosis (South Korea)CompletedNCT00425113Phase 2Results posted
• Safety and Immunogenicity of 2 Formulations of Tuberculosis Vaccine GSK692342 Given at 0,1 Months to Healthy AdultsCompletedNCT00397943Phase 2Results posted
• Early Bactericidal Activity of Linezolid, Gatifloxacin, Levofloxacin, Isoniazid (INH) and Moxifloxacin in HIV Negative Adults With Initial Episodes of Sputum Smear-Positive Pulmonary TuberculosisCompletedNCT00396084Phase 1/2Results posted
• Characteristics and Prevalence of Tuberculosis and HIV in Masiphumelele Township, Cape Town, South AfricaCompletedNCT00346476Results posted
• Effects of Interferon-Gamma on Cavitary Pulmonary Tuberculosis in the LungsCompletedNCT00201123Phase 2Results posted
• TBTC Study 26 PK: Rifapentine Pharmacokinetics in Children During Treatment of Latent TB InfectionCompletedNCT00164450Not applicableResults posted
• Study of Limited Versus Continuous Isoniazid Tuberculosis Preventive Therapy in HIV-infected Persons in BotswanaCompletedNCT00164281Phase 4Results posted
• Tuberculosis Treatment Shortening TrialCompletedNCT00130247Phase 3Results posted
• Service Development: Assessing Non-attendance Rates in Outpatient ClinicsCompletedNCT00129649Not applicableResults posted
• Treatment of Latent TB Infection for Jailed PersonsCompletedNCT00128206Phase 3Results posted
• Immediate Versus Deferred Start of Anti-HIV Therapy in HIV-Infected Adults Being Treated for TuberculosisCompletedNCT00108862Phase 4Results posted
• Prevalence of HIV and Tuberculosis in Masiphumelele Township, Cape Town, South AfricaCompletedNCT00096681Results posted
• Moxifloxacin As Part of a Multi-Drug Regimen For TuberculosisCompletedNCT00082173Phase 2Results posted
• Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIVTerminatedNCT00080119Phase 2/3Results posted
• Three Months of Weekly Rifapentine and Isoniazid for M. Tuberculosis InfectionCompletedNCT00023452Phase 3Results posted
• Usability mTBScreenCompletedNCT07840989
• Tuberculosis Sentinel Research Network (TB-SRN)Active, not recruitingNCT07798167
• KAP TB in Senior Management Officials of Companies With Increased Silica ExposureCompletedNCT07749872
• Shorter Treatment Regimen Implementation Evaluation StudyCompletedNCT07747792
• Prophylaxis of Complications of Basic Therapy Using Naderin in Socially Significant DiseasesCompletedNCT07671508Phase 2/3
• C-TST for Diagnosis of Latent Mycobacterium Tuberculosis Infection in IndonesiaCompletedNCT07587164Not applicable
• Vitamin D and Immune Response in Pulmonary Tuberculosis With and Without Chronic Pulmonary AspergillosisActive, not recruitingNCT07516158

← Tuberculosis overview